Scalp cooling to reduce hair loss during breast cancer chemotherapy
Treatments studied
Part of Cancer, Skin clinical trials.
This Phase 2 trial tests whether using a scalp-cooling device during chemotherapy can help prevent or lessen hair loss in people with metastatic invasive breast cancer. You would need to be starting a specific chemotherapy plan and be willing to begin scalp cooling with your first treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older and have metastatic invasive breast cancer that has spread
- Your overall health is fairly good (ECOG 0–2) as judged by your clinician
- You currently have hair at the start (not already missing hair from baseline hair loss)
- You must be planning at least 4 cycles of one of the listed chemotherapy treatments and start cooling with the first dose
- You cannot have certain conditions: leukemia/lymphoma, scalp metastases, cold urticaria/cold agglutinin disease, or planned bone marrow ablation chemotherapy
- You cannot have migraine/cluster/tension headache diagnosed by a doctor (unless the team says a past resolved issue is okay), and you cannot have lichen planus or lupus
- You cannot be taking any other anti-cancer medicines at the same time as the study treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
This study tests whether photobiomodulation (a specific light therapy) can prevent or reduce hair loss caused by chemotherapy. It may help you keep more hair or grow hair back sooner while you’re getting treatment.
This trial tests whether minoxidil (a hair-regrowth medication) alone or combined with red-light therapy can help hair grow back after breast cancer chemotherapy. The goal is to help patients recover from chemotherapy-induced hair loss.
This trial tests a treatment called DA-007 to see if it can prevent hair loss caused by chemotherapy in people with early-stage breast cancer. If you are about to start chemotherapy with taxane or anthracycline drugs, this study might help you keep your hair.
This trial tests a device called Lily that you wear during and after chemotherapy to help prevent hair loss. It's for people with breast cancer who are about to start specific types of chemo.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.